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Dendritic cells (DCs), Langerhans cells (LCs), and macrophages are innate immune cells
that reside in genital and intestinal mucosal tissues susceptible to HIV-1 infection. These
innate cells play distinct roles in initiation of HIV-1 infection and induction of anti-viral immu-
nity. DCs are potent migratory cells that capture HIV-1 and transfer virus to CD4+ T cells in
the lymph nodes, whereas LCs have a protective anti-viral function, andmacrophages func-
tion as viral reservoirs since they produce viruses over prolonged times.These differences
are due to the different immune functions of these cells partly dependent on the expres-
sion of speciﬁc pattern recognition receptors. Expression ofToll-like receptors, C-type lectin
receptors, and cell-speciﬁcmachinery for antigen uptake and processing strongly inﬂuence
the outcome of virus interactions.
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INTRODUCTION
The innate immune system forms the ﬁrst line of defense against
invading pathogens. Innate immune cells, such as dendritic cells
(DCs), Langerhans cells (LCs), and macrophages reside within
mucosal tissues. Themain route of HIV-1 infection is sexual trans-
mission and therefore the interplay between the virus and innate
immune cells within themucosa plays a crucial role in initiating an
effective immune response as well as dissemination of the virus.
HIV-1 infects CD4+ T cells within the secondary lymph nodes
and innate immune cells are thought to be involved in transmit-
ting virus to these T cells. HIV-1 infects cells upon interaction
of viral envelope protein gp120 with CD4 and co-receptors, such
as CCR5 or CXCR4, which initiate fusion of the virus with the
cell membrane. Besides CD4+ T cells, DCs, LCs, andmacrophages
also express CD4 and CCR5. The exact roles of the different innate
immune cells uponvirus entry into thehost, andwhether the inter-
actions with the virus by these cells are beneﬁcial to host or virus,
are not yet clear. However, their function in HIV-1 transmission
is strongly inﬂuenced by expression of pattern recognition recep-
tors (PRRs) including C-type lectin receptors (CLRs). Extensive
research during the last decade has given us more insight into
the different events that follow upon HIV-1 binding to innate
immune cells, which are related to cell-speciﬁc functions, receptor
expression, and receptor signaling.
MUCOSAL ENTRY
Over 80% of newHIV-1 infections globally occur via sexual trans-
mission (UNAIDS, 2010). The ﬁrst barrier that HIV-1 encounters
is the epithelium of the genital and intestinal tract. Epithelial cells
do not express CD4 but these cells can be involved in HIV-1
transmigration albeit not efﬁciently. Syndecans, a speciﬁc class
of heparin-sulfate proteoglycan, mediate internalization of HIV-
1 through gp120 (Bobardt et al., 2007) and gp120–epithelial cell
interaction decreases transepithelial resistance (Nazli et al., 2010).
The latter occurs via induction of inﬂammatory cytokines and
subsequent downregulation of junction genes, which facilitate
transport of HIV-1 across the epithelial barrier. However, DCs
or LCs are proposed as initial target cells of HIV-1 that mediate
transfer of the virus to CD4+ T cells in the draining lymph nodes,
which is supported by both ex vivo and in vivo studies, (Spira et al.,
1996; Hu et al., 2000; Gupta et al., 2002; Veazey et al., 2003; Hladik
et al., 2007).
MUCOSAL INNATE IMMUNE CELLS
Innate immune cells residing in the mucosa express PRRs includ-
ing Toll-like receptors (TLRs) and CLRs to sense pathogens and
pathogenic-derived structures. Viral internalization takes place
via receptor-mediated clathrin- or caveolin-dependent endo-
cytosis, receptor-mediated phagocytosis, or through receptor-
independent macropinocytosis (Trombetta and Mellman, 2005;
Burgdorf andKurts, 2008). Subsequently,uptake leads to pathogen
degradation and antigen presentation to T cells to initiate immune
responses (Banchereau et al., 2000; Romani et al., 2010). In addi-
tion, recognition of pathogenic structures by PRRs causes activa-
tion andmaturation of the cells. Maturation leads to upregulation
of costimulatorymolecules to effectively present antigens and acti-
vate T cells. PRR signaling is not only required for maturation of
the cells, but also induces a pathogen-tailored cytokine program
that shapes speciﬁc immunity through T helper cell polarization
(Banchereau et al., 2000). The extent to which maturation and
activation is induced by HIV-1 is controversial. Reports on LC
and DC maturation in response to HIV-1, or to other stimuli
after HIV-1 exposure are contradicting, and resultsmight be inﬂu-
enced by virus and cell preparations (Granelli-Piperno et al., 2004;
Smed-Sorensen et al., 2004; Harman et al., 2006). Understanding
of immune activation in the early events of HIV-1 infection is cru-
cial, since activation, and maturation by HIV-1 or co-infections
affects not only viral uptake and transmission, but also induc-
tion of adaptive immune responses and the presence of immune
cells in the mucosa (Patterson et al., 2002; Baﬁca et al., 2004;
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Turville et al., 2004). Although it is unclear how direct activation
by HIV-1 occurs, HIV-1 modulates adaptive immunity induced
by other stimuli through interactions with DC-SIGN (Gringhuis
et al., 2009).
In the female genital tract, mucosal tissue consists of a single
layer of endocervical columnar epithelium or squamous epithe-
lium of vagina and ectocervix. Although some studies report
slightly different expression patterns of widely used markers, in
general LCs – deﬁned by expression of CD1a and Langerin –
are present within the epithelium. Intraepithelial and beneath
this layer in the submucosa, CD11c+ DCs, CD68+macrophages,
and CD4+ T cells, are localized (Geijtenbeek et al., 2000; Hladik
et al., 2007; Hirbod et al., 2009, 2011). Also in the intestinal tract,
foreskin, and rectum,DC, LCs, andmacrophages are present (Gei-
jtenbeek et al., 2000; Patterson et al., 2002; Gurney et al., 2005;
Ribeiro Dos Santos et al., 2011).
Dendritic cells, LCs, and macrophages have their speciﬁc func-
tion in the immune system. Macrophages continually display
phagocytic activity and are prone to initiate local inﬂammation
and persist in the tissue (Cassol et al., 2010). DCs on the other
hand are equipped to rapidly migrate to the lymph nodes, and
therefore have a bridging function between innate and adaptive
immunity (Banchereau et al., 2000). LCs belong to the DC fam-
ily and are thought to have an important function to maintain
mucosal homeostasis (von Bubnoff et al., 2004; Chu et al., 2011).
It is not clear whether LCs are as efﬁcient in their antigen present-
ing functions as DC, since compared to conventional DCs, these
cells have slower migratory capacities (Villadangos and Heath,
2005; Romani et al., 2010). Innate immune cells express CD4 and
coreceptors, required for HIV-1 infection, as well as PRRs that
sense viruses to initiate immune activation. These include TLRs
to recognize viral nucleic acids and CLRs that besides sensing can
also function as viral attachment receptors. Furthermore, besides
CLRs, syndecans can also function as attachments receptor on
innate immune cells (Saphire et al., 2001; de Witte et al., 2007a).
PATTERN RECOGNITION RECEPTORS IN HIV-1 INFECTION
Infected DCs, LCs, and macrophages have been observed shortly
after sexual transmission (Spira et al., 1996; Collins et al., 2000;
Hu et al., 2000; Patterson et al., 2002; Hladik et al., 2007), strongly
suggesting that these innate immune cells are an initial target for
HIV-1. In addition to entry receptors, infection of innate immune
cells is inﬂuenced by expression of CLRs and TLRs via internaliza-
tion and/or immune activation.Whereas fusion of HIV-1 depends
on CD4 and coreceptors, internalization and uptake depends on
CLRs. CLRs recognize glycosylated structures via conserved car-
bohydrate recognition domains (Cambi et al., 2005; Robinson
et al., 2006) and the heavily glycosylated HIV-1 envelope glyco-
protein gp120 is recognized by mannose-speciﬁc CLRs such as
dendritic cell speciﬁc ICAM-3 grabbing non-integrin (DC-SIGN),
LC-speciﬁc Langerin, and the mannose receptor (MR). A recent
study suggests that gp120 is also recognized by DC Immunore-
ceptor (DCIR) but the carbohydrate structures recognized are
not clear (Lambert et al., 2008). MR, DC-SIGN, and DCIR are
expressed by speciﬁc macrophage and DC subsets (Turville et al.,
2001, 2002; Lambert et al., 2008). Langerin is speciﬁc for LCs in
humans (Valladeau et al., 1999). In mice, a Langerin expressing
DC subset has been identiﬁed, but its human homolog is not yet
clear (Ginhoux et al., 2007) DC-SIGN, MR, and DCIR promote
infection of innate immune cells but also transmission of HIV-1
to target T cells, while Langerin prevents infection through viral
degradation (deWitte et al., 2008; van derVlist et al., 2011). There-
fore, expression of speciﬁc CLRs inﬂuences infection and HIV-1
internalization and at least partly determines the role of the innate
immune cells in HIV-1 transmission.
Toll-like receptors comprise a family of plasma membrane and
intracellular receptors. DCs and macrophages express a variety of
TLRs (TLR1-8 and TLR10) to recognize bacterial and viral ligands
(Kawai and Akira, 2011). Regarding HIV-1 recognition, HIV-1-
derived ssRNA is sensed by TLR7/8 (Heil et al., 2004), although a
recent study shows that infection of DCs triggers TLR8 but not
TLR7 (Gringhuis et al., 2010), suggesting that TLR8 might be
more important in HIV-1 sensing. LCs mainly express TLRs for
recognition of viral products and lack TLR4. However, expression
of TLR7/8 by LCs is debated (Flacher et al., 2006; van der Aar
et al., 2007). Most TLRs are constitutively expressed in the genital
mucosa but expression is tightly regulated, and both TLR2 and
TLR4 seem restricted to the upper parts of the tract (Pioli et al.,
2004; Fazeli et al., 2005), suggesting that the site of mucosal trans-
mission might inﬂuence immune activation. TLR activation leads
to innate immune activation aswell as adaptive immune responses.
Antiviral TLRs speciﬁcally induce production of interferons that
interfere with virus replication (Bowie and Unterholzner, 2008;
Ogawa et al., 2009). As a consequence, TLR4 signaling in DCs
andmacrophages decreases infection of the cells (Kornbluth et al.,
1989; Thibault et al., 2009;Wang et al., 2011),whereas signaling via
TLRs has also been shown to promote HIV-1 infection in innate
cells directly through signaling and promoting HIV-1 transcrip-
tion or indirect through cytokine induction (Table 1; Baﬁca et al.,
2004; Gringhuis et al., 2010; Herbein et al., 2010). However, the
effect of TLR triggering on HIV-1 infection as well as the effect of
infection on PRR function depends on the innate immune cell a
well as the receptor. Thus, TLR expression on innate immune cells
and pathogen-driven TLR activation in the mucosa affects HIV-1
transmission.
Besides CLRs and TLRs, cytoplasmic tripartite motif-
containing protein 5α (TRIM5α) acts as a PRR in myeloid cells.
Retrovirus restriction factor TRIM5α interacts with the HIV-1
capsid (Stremlau et al., 2004), accelerates uncoating of the virus
and thereby prevents reverse-transcriptase (Stremlau et al., 2006).
However, recently another function of TRIM5α was described.
HIV-1 capsid interaction with TRIM5α generates ubiquitin chains
that activate the TAK1 kinase complex and subsequenlty activate
transcription factors NFκB and AP-1 (Pertel et al., 2011). Notably,
TRIM5α constitutively promotes innate immune signaling and
sensing of retroviral capsids increases inﬂammatory gene tran-
scription as well as retroviral restriction activity. Thus, TRIM5α
can act as a PRR and activate innate signaling in response to retro-
viral infection. The importance in HIV-1 infection and sensing
needs to be investigated.
LANGERHANS CELLS
Due to their localization in the epithelium LCs are the ﬁrst cells to
encounter HIV-1 and therefore regarded as “primary gatekeepers”
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Table 1 | Examples of PRR-mediated effects on HIV infection in innate immune cells.
Pathogen Cell type Effect on HIV infection Receptors involved References
Mycobacterium tuberculosis Macrophage Increased replication, transmission, LTR activation TLR2 Zhang et al. (1995),
Mancino et al. (1997)
Neisseria gonorrhoeae DC Increased entry/replication TLR2 Zhang et al. (2005)
LC Increased transmission TLR1/2 de Jong et al. (2008)
Lactobacillus acidophilus Macrophage Increased infection TLR2 Ahmed et al. (2010)
Leishmania donovani Macrophage Increased replication TLR2 Bernier et al. (1995)
Candida albicans LC Increased transmission TLR1/2 de Jong et al. (2008)
Escherichia coli Macrophage Reduced infection TLR4 Ahmed et al. (2010)
Staphylococcus aureus DC Reduced infection TLR4 Ogawa et al. (2009)
LC Increased infection
Salmonella typhimurium DC Reduced infection TLR4 Ogawa et al. (2009)
LC No effect
Herpes simplex virus-2 LC Increased infection, transmission Langerin de Jong et al. (2010)
LIGANDS
Pam3Cysk4, LTA DC Increased transmission TLR2 Thibault et al. (2009)
LPS DC, macrophage Reduced infection/transmission, replication TLR4 Kornbluth et al.
(1989), Thibault et al.
(2009),Wang et al.
(2011)
Interferon Macrophage Reduced infection, replication TLR3 Kornbluth et al.
(1989), Ahmed et al.
(2010)
(Kawamura et al., 2003). Infected mucosal LCs have been iden-
tiﬁed as early target cells in foreskin and vagina (Hu et al., 2000;
Patterson et al., 2002;Hladik et al., 2007). However, althoughHIV-
1 is very rapidly internalized by these cells, infection of immature
LCs is very inefﬁcient (de Witte et al., 2007b; Hladik et al., 2007;
Ballweber et al., 2011). LCs bind gp120 predominantly through the
CLRLangerin (Turville et al., 2002; deWitte et al., 2007b). Notably,
HIV-1 virions captured by Langerin are directed to birbeck gran-
ules for degradation (de Witte et al., 2007b). As a consequence,
immature LCs do not promote T cell infection (de Witte et al.,
2007b; Fahrbach et al., 2007) (Figure 1). The outcome of LC inter-
action with HIV-1 is mainly determined by their activation status.
In contrast to immature LCs, activated LCs transmit HIV-1 to T
cells (deWitte et al., 2007b; Fahrbach et al., 2007). Transmission by
LCs to T cells is considered to be dependent on LC infection, since
infected LCs effectively transmit HIV-1 to T cells (Reece et al.,
1998; Kawamura et al., 2000; Sivard et al., 2004; de Jong et al.,
2008), although it has been reported that LCs are able to transfer
virus to T cells independent of infection (Hladik et al., 2007; de
Jong et al., 2008; Ballweber et al., 2011).
Langerhans cell activation, and subsequently enhanced infec-
tion as well as transmission is induced by co-infections, and
explains partly the increased risk of HIV-1 infection in persons
carrying other sexually transmitted diseases. Gram+ bacteria,
Candida albicans, and Neisseria gonorrhea enhance capture, repli-
cation, and transmission via induction of TNF-α ormodulation of
the interferon response as a result of TLR1/TLR2 binding (de Jong
et al., 2008; Ogawa et al., 2009). On another level, Herpes Simplex
Virus-2 interferes with the protective role of Langerin by compet-
ing for receptor binding and decreasing expression levels (de Jong
et al., 2010). Thus, immune activation is a critical determinant in
susceptibility to HIV-1.
Immature LCs have a protective role in infection, which dras-
tically changes upon cell maturation as mature LCs effectively
transfer HIV-1. Because of the striking differences between imma-
ture and activated LCs in virus degradation and transmission
respectively, LCs play a pivotal role in HIV-1 transmission.
DENDRITIC CELLS
Infected DCs and DC-T cell conjugates have been observed soon
after infection in vaginal and rectal tissue. Within hours upon
exposure, HIV-1 infected cells were detected in draining lymph
nodes (Spira et al., 1996; Hu et al., 2000; Ribeiro Dos Santos et al.,
2011). DCs are the most potent APCs, capable of rapid migration
to the lymph nodes to present antigens to T cells and therefore
it has been proposed that DCs migrate to the lymph node where
they transfer HIV-1 to T cells (Figure 1).
Dendritic cells binding and internalization of HIV-1 is mainly
facilitated by DC-SIGN and DC-SIGN-bound virions remain
infectious for days allowing transmission independent of infec-
tion, supporting a role for DCs in viral transport (Geijtenbeek
et al., 2000; Kwon et al., 2002). However, DCs are also infected
by HIV-1. The importance of direct infection compared to HIV-1
capture depends on the time scale. Whereas DC-SIGN-captured
virus can be transmitted for several days, Turville et al. (2004)
have shown that after two days DC infection becomes more
important in HIV-1 transmission. Furthermore, DC infection
might lead to the formation of HIV-1 reservoirs as has been
shown formacrophages (Coleman andWu, 2009). Both immature
and mature DCs internalize HIV-1 and facilitate trans-infection.
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FIGURE 1 |The role of innate immune cells in HIV-1 infection largely
depends on PRR expression. Innate immune cells reside in mucosal and
submucosal tissue. DCs internalize HIV-1 and migrate to the lymph node to
transfer virus to CD4+ T cells and this process is mediated by DC-SIGN.
Immature LCs express Langerin, which promotes viral degradation in Birbeck
granules. Macrophages take up HIV-1 via MR, but are most important as an
HIV-1 reservoir. All three innate immune cells in addition express various
TLRs on the cell surface and in endosomes to sense pathogenic-derived
antigens. Subsequent TLR signaling inﬂuences HIV-1 infection and immune
activation.
Immature DCs capture HIV-1 more efﬁciently and infection is
higher, whereas mature DCs most efﬁciently transfer virus to T
cells (Turville et al., 2004;Yu et al., 2008). In addition to promoting
viral transfer, virus capture through DC-SIGN favors infection of
DCs since DC-SIGN colocalizes with CD4 and CCR5 and thereby
promotes binding to the fusion receptors (Lee et al., 2001). Strik-
ingly, DC-SIGN signaling is also crucial for initiation of HIV-1
transcription. Notably, other pathogens that interact with DC-
SIGN also induce DC-SIGN signaling and thereby enhance HIV-1
transcription (Gringhuis et al., 2010). In addition to internaliza-
tion, DC-SIGN ligation and T cell contact induce formation of a
virological synapse to which HIV-1-containing vesicles are rapidly
recruited for transfer (McDonald et al., 2003; Arrighi et al., 2004;
Turville et al., 2004). Although the virological synapse is reminis-
cent of immunological synapse it forms independent of antigen
presentation or MHC–TCR interactions (Piguet and Sattentau,
2004). Different models have been proposed regarding how HIV-
1 in DCs is protected from degradation and whether the virus
is internalized upon DC-SIGN binding and if so, to what com-
partments it is directed to enable transfer to T cells. It has been
proposed that themajority of transferred virus is retained surface-
bound (Cavrois et al., 2007), but most studies support a model in
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whichHIV-1 is internalized into compartments that do not belong
to the classical endosomal/lysosomal pathway. Here the virus is
protected from lysosomes andneutralizing antibodies (Kwon et al.,
2002; McDonald et al., 2003; Turville et al., 2004). Slightly dif-
ferent models have been proposed where HIV-1 induces speciﬁc
surface-accessible CD81+ vesicles, contiguous with the plasma
membrane to protect the virus from lysosomal degradation (Yu
et al., 2008). Furthermore, it has been suggested that HIV-1 makes
use of the exosome pathway to be secreted for transmission (Wiley
and Gummuluru, 2006), which is supported by suggestion that
HIV-1 particles contain similar proteins and lipids as exosomes
(Gould et al., 2003). Exploitation of the exosome pathway by
HIV-1 for transfer to T cells has also been proposed to occur
independent of gp120 and CLRs (Izquierdo-Useros et al., 2009).
Notably, the exosome pathways contain tetraspanin proteins, such
as CD81, also found in HIV-1-containing multivesicular bodies,
whichmight be involved in exosomeproduction andmight explain
presence of HIV-1 in exosomes.
Over the last few years, some underlying mechanisms of DC-
SIGN signaling, and how these events affect transmission, have
become clear. DC-SIGN–HIV-1 interaction leads to recruitment
of Guanine exchange factor (GEF) LARG and RhoA to the DC-
SIGN signalosome and in turn activation of kinase Raf-1. Through
Raf-1 activation, DCs shape adaptive immune responses to HIV-
1 (Gringhuis et al., 2009). However, Raf-1 activation by HIV-1
is also required for HIV-1 replication in DCs (Gringhuis et al.,
2010). Multiple studies focused on how proteins involved in DC-
SIGN signaling affect internalization and synapse formation by
inﬂuencing motility or arrangement of the cytoskeleton. Speciﬁ-
cally, DC-SIGN-mediated activation of LARG induces cytoskele-
ton rearrangements that are important for the formation of the
virological synapse (Hodges et al., 2007), whereas DC-SIGN acti-
vation of Rho-GTPase cdc42 is crucial for the induction of mem-
brane extensions and recruitment of virus to the synapse (Nikolic
et al., 2011). Scaffolding protein LSP1, part of the DC-SIGN
signalosome, is proposed tomediate transfer to the proteasome for
degradation and thus has a negative role for transmission (Smith
et al., 2007). LSP1 is involved in chemotaxis of DCs, but LSP1-
induced cell motility is also facilitated by gp120–CCR5 interaction
(Anand et al., 2009), indicatingmultiple HIV-1 receptors might be
involved in transmission events.
DC-SIGN is the most studied CLR regarding HIV-1 due to its
special role in promoting infection and transmission, but other
CLRs expressed by DCs, including DCIR and MR, have been
demonstrated to interact with HIV-1. Although not much known
about the function of DCIR in DCs, and no speciﬁc ligands have
been described, binding of HIV-1 to DCIR enhances infection of
DCs and transmission tot T cells (Lambert et al., 2008). DCIR
is the only CLR expressed on DCs containing an intracellular
immunoreceptor tyrosine-based inhibitorymotif (ITIM), and this
intracellular part is required for its effect on infection (Lambert
et al., 2008, 2011).MR has been suggested to internalize and trafﬁc
virus to endosomes and lysosomes upon binding gp120 (Turville
et al., 2004). Thus MR interaction might promote degradation
and MHCII Ag presentation in DCs. Capture via DC-SIGN has
also been proposed to promote antigen presentation, both in the
context of MHCI, following fusion and proteosomal degradation,
or MHCII via a pathway independent of productive infection
(Moris et al., 2004, 2006). Thus, DC-SIGN, but also other CLRs
are involved in uptake of HIV-1 leading to transmission or antigen
presentation.
Similar to macrophages, involvement of TLRs can be detri-
mental for DC infection. Although both TLR2 and TLR4 ligands
enhance entry, only TLR2 ligands, such as Neisseria gonorrhoeae,
enhance infection, and transmission of DCs through signaling
(Zhang et al., 2005), whereas TLR4 triggering decreases due to
interferon induction and TLR5 TLR7/9 have no effect (Thibault
et al., 2009). Strikingly, although HIV-1 RNA efﬁciently activates
plasmacytoid DCs through TLR7 and TLR9, it does not activate
conventional DCs through TLR7 and TLR8 (Beignon et al., 2005).
Recent data show that TLR8 triggering and NF-κB activation is
required for HIV-1 infection in DCs (Gringhuis et al., 2010), sug-
gesting that HIV-1 additional signals are required for activation in
DCs.
Dendritic cells express several CLRs that promote infection
and viral transfer to T cells. Virus interaction with DC-SIGN
induces internalization into speciﬁc vesicles and formation of a
virological synapse to facilitate transmission. DCs therefore have
an important role in virus dissemination.
MACROPHAGES
Infected macrophages are detected in the female genital tract soon
after exposure to HIV-1 (Collins et al., 2000). However, compared
to DCs and LCs, macrophages do not seem to be important in
initiation of infection, since they do not have a clear protective or
HIV-1 transmitting function.
Uptake of HIV-1 by macrophages can occur dependent or
independent of CLR binding. Uptake has been shown to occur
by macropinocytosis, leading to degradation of many particles
in lysosomes (Marechal et al., 2001). An additional receptor-
mediated phagocytosis pathway was described, which is induced
by interaction with MR, accounting for a large part of HIV-1
binding (Nguyen andHildreth, 2003).Virus–MR interactions lead
to degradation via clathrin-dependent lysosomal pathway and
antigen presentation whereas the interactions do not promote
infection (Trujillo et al., 2007). Besides its role in antigen presenta-
tion,MR is also involved in HIV-1 transmission (Nguyen and Hil-
dreth, 2003). In contrast to DC-SIGN, MR-mediated uptake does
not lead to protection of HIV-1, supporting a function in antigen
degradation and presentation similar to its role in DCs (Nguyen
and Hildreth, 2003). Recently a novel uptake route, an alternative
macropinocytosis pathway, has been described. This entry route,
independent of caveolin, clathrin and PI3K, but dependent on
actin, Rho family GTPases, and dynamin leads to infection by
HIV-1. How this pathway is induced and whether MR is involved
is not known (Carter et al., 2010).
Since macrophages do not migrate after activation, their func-
tion in initial dissemination of HIV-1 to T cells is limited.However
infected macrophages are an important HIV-1 reservoir, and very
capable of infecting T cells over a prolonged time period. Within
multivesicular bodies, de novo produced virus can persist and
retain infectious for weeks to infect T cells (Carr et al., 1999;
Sharova et al., 2005) (Figure 1). Stored virus from the CD81+
compartments can be transmitted in a regulated way to T cells
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via transient synapse formation (Deneka et al., 2007; Groot et al.,
2008). Similarly, the exosome pathway might be involved, since
exosomes are derived from multivesicular bodies (Denzer et al.,
2000). Thus, macrophages as reservoirs might facilitate infection
of other cells including T cells but also DCs in mucosal tissues. It
is however unclear whether a reservoir role for macrophages is rel-
evant in mucosal tissue direct after sexual transmission since the
replication capacity of transmitted/founder virus in macrophages
is lower compared to HIV strains used in most in vitro studies
(Ochsenbauer et al., 2012).
Macrophage activation by TLR ligands inﬂuences HIV-1 infec-
tion. Interferon-inducing ligands or pathogens that trigger TLR3
TLR4, TLR7/8 have been shown to impair replication (Kornbluth
et al., 1989; Wang et al., 2011), while infection with pathogens
that trigger TLR2 increase virus production (e.g., M. tubercu-
losis) or do not affect infection (Mancino et al., 1997; Baﬁca
et al., 2003; Ahmed et al., 2010). This suggests that depending
on the pathogen, co-infections increase, or protect from HIV-1
replication in macrophages in the mucosa.
Macrophages seem to function as reservoirs for HIV-1 and
therefore are able to transmit virus to T cells or DCs residing
in mucosal tissues. As opposed to DCs, HIV-1 capture leads also
to degradation and Ag presentation and therefore HIV-1 infection
of macrophages is a major factor in their role as HIV-1 reservoir.
FUTURE DIRECTIONS AND CONCLUDING REMARKS
Innate immune cells reside in the tissues where HIV-1 enters the
body. Their capacity to capture and digest pathogens, and subse-
quently interact with T cells, contributes to mechanisms of viral
transfer to CD4+ T cells. Cell-speciﬁc CLRsmediate HIV-1 degra-
dation, antigen processing, or in the case of DC-SIGN protection
of HIV-1. Multiple HIV-1 binding CLRs and PRR-induced path-
ways inﬂuence dissemination or degradation by innate immune
cells and dominance of one particular pathway will depend on
activation status of the innate immune cell. Our knowledge of
mechanisms underlying these events has improved greatly, but
some important questions remain and might be crucial to answer
before effective prevention methods can be developed. For exam-
ple, the reason why sexual transmission of HIV-1 is restricted to
R5 strains remains to be elucidated. DCs are infected with and
transmit both X4 and R5 strains, and mucosal T cells express both
coreceptors (Geijtenbeek et al., 2000; Kwon et al., 2002; Veazey
et al., 2003). LCs are primarily infected with R5 virus, although
X4 transmission has been observed as well, indicating the need for
additional research on this topic (Sivard et al., 2004; de Jong and
Geijtenbeek, 2009). Secondly, non-human primate studies provide
a valuable tool for in vivo pathogenesis studies and drug testing.
Although the SIV infection in macaques is similar to HIV infec-
tion in humans, differences in disease progression and host factors
must be kept in mind (Sina et al., 2010; Van Rompay, 2012). The
importance of the described mechanisms in vivo is another point
of debate. Contradicting ﬁndings can be explained by the use of
different experimental setups, ex vivo models or use of speciﬁc
differentiation methods for DCs, LCs, or macrophages. In addi-
tion, the in vivo plasticity of the phenotype and function of innate
immune cells makes it difﬁcult to translate all results to the in vivo
situation (Geissmann et al., 2010;Galli et al., 2011). Still, an impor-
tant role for CLR in HIV-1 transmission in vivo is illustrated by a
recent ﬁnding that expression of Langerin, DC-SIGN, and MR,
but not HLA-DR, is signiﬁcantly higher in mucosa of a high-
risk population (Hirbod et al., 2009). But whether this increased
expression is protective or detrimental for the host cannot be
answered.
During the last years, the focus of HIV-1 transmission research
has shifted toward a more immunological approach. Elucidating
intracellular signaling and cellular effects following HIV-1 inter-
action will contribute to a better understanding of the ﬁrst events
upon sexual transmission.
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